Mindray, Alibaba, and MIIT in one day: MedTech World Asia 2026 extends into Shenzhen with exclusive GBA tour

This year, MedTech World Asia 2026 goes beyond Hong Kong. The official programme has been extended by one day, taking delegates across the border into Shenzhen and the Greater Bay Area.

For international MedTech companies serious about scaling in Asia, the opportunity rarely lies in a single market. China’s Greater Bay Area, anchored by Shenzhen, one of the world’s most dynamic health technology ecosystems, represents a gateway to manufacturing muscle, regulatory intelligence, and partnership pipelines that most executives only read about. On 29 August, the day after MedTech World Asia 2026 closes, a curated Study Tour will take a select group of senior leaders directly into that ecosystem. This is not a sightseeing itinerary. It is a precision-engineered day of access.

Secure your place on the Shenzhen and Greater Bay Area Study Tour. Spaces are strictly limited.

Access that money can’t simply buy

The Shenzhen and Greater Bay Area Study Tour, sponsored by Smart City of China, is built around one premise: that real market entry in China happens through trust, proximity, and the right introductions, not cold emails or trade directories.

The day begins with a visit to Mindray, one of China’s most globally recognised medical device companies and a bellwether for where the domestic sector is heading. For international players looking to understand the competitive landscape, distribution dynamics, or potential co-development pathways, a structured engagement with Mindray is the kind of conversation that typically takes months to arrange independently.

From there, the group moves to the Alibaba Group, where the afternoon session takes on a distinctly strategic character. At Alibaba’s Shenzhen Innovation Center, representatives from the China Centre for Promotion of SME Development, a directly affiliated institution of Ministry of Industry and Information Technology (MIIT), will join senior executives from leading Shenzhen-headquartered companies in medical devices, biopharmaceuticals, and medical consumables. This is not a panel discussion viewed from a distance. It is a roundtable-style exchange, with government and industry decision-makers in the same room, focused on real collaboration and business opportunity.

For any company navigating China market entry, regulatory pathways, or technology transfer questions, having a direct line to MIIT representatives in an informal, relationship-first setting is extraordinary.

Why Shenzhen, why now

Shenzhen sits at the heart of the Greater Bay Area, China’s flagship initiative to create an integrated innovation economy spanning eleven cities and over 86 million people. The city has evolved from a manufacturing base into a full-stack health technology hub, home to global leaders in diagnostics, surgical robotics, wearables, and digital health infrastructure.

For MedTech companies looking to scale in Asia, Shenzhen is not just a market. It is a mirror of where Asian healthcare is going. Supply chains originate here. Regulatory standards are shaped here. And increasingly, clinical data, AI-driven diagnostics, and health system partnerships are incubated here before reaching the rest of the region.

The Study Tour is designed to give participants a compressed but substantive read of this environment, not through presentations, but through interaction.

Already attending MedTech World Asia 2026? Add the Study Tour to your programme before spaces close.

The format: Structured for relationships, not tourism

The day is paced deliberately. Senior executives from invited Shenzhen-headquartered companies will be present not as hosts but as participants, meaning the peer exchange is substantive and mutual. Business lunches and afternoon networking sessions are woven into the schedule, giving delegates unstructured time to follow up on morning discussions, explore bilateral interest, or simply build the kind of rapport that converts into partnership.

The programme wraps at 17:00, with guests transferred back to Shenzhen Bay Port. From there, delegates may cross independently back to Hong Kong or stay on in Shenzhen, an option that speaks to how much some participants will want to extend the conversations they have started.

Who this day is for

If you are a medical device manufacturer looking to understand China’s domestic competitive set. If you are a health tech company exploring manufacturing partnerships or distribution agreements in the GBA. If you are an investor or accelerator mapping the next wave of Asian medtech origination. If you are a hospital group or procurement leader looking to understand supply chain options at source, this day was designed with you in mind.

The Study Tour is not a mass-attendance event. Access is structured, curated, and capped to ensure the quality of every interaction. That is precisely the point.

It starts in Hong Kong

None of this happens in isolation. The Shenzhen and Greater Bay Area Study Tour is an extension of MedTech World Asia 2026, taking place in Hong Kong from 26 to 28 August, Asia’s defining gathering for the global medical technology industry. Three days of keynotes, deal-making, regulatory dialogue, startup pitches, company showcases, and peer exchange, followed by one day of on-the-ground immersion in the market that is reshaping Asian healthcare.

If you have been trying to figure out what the MedTech World Asia 2026 conversation is really about, what is driving the energy, the investment, and the ambition around Asia as the next frontier for scaling health innovation, the answer starts in Hong Kong and continues across the border.

Register for MedTech World Asia 2026 and add the Shenzhen and Greater Bay Area Study Tour to your programme. Spaces are limited. The opportunity is not.